Yes, alterations in metaphase can serve as biomarkers for exposure to genotoxic agents. The presence of aberrant metaphase configurations in cells can indicate exposure to harmful substances. These biomarkers are crucial for risk assessment and regulatory toxicology, providing evidence of potential health risks posed by environmental and occupational exposures.